Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled NO for the Prevention of Chronic Lung Disease
NCT00006401Phase 3Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2000
- Primary completion
- Sep 2005
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in bronchopulmonary dysplasia (BPD), sponsored by University of Colorado Denver. Started Sep 2000; status: completed.
02
Drugs
nitric oxide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT00006401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006401.